Home AUM LifeTech

AUM LifeTech

In operation
-
Disease Treatment Drug Developer
Basic
Enterprise Profile

Basic Information

AUM LifeTech is a Philadelphia-based biotechnology company with a revolutionary nucleic acid platform in the field of gene silencing and regulation. Our mission is to harness the power and adaptability of our unique FANA ASO RNA silencing technology to treat and find cures for certain genetically defined diseases. To achieve this, our technology relies on one of the most important molecules in vivo: RNA. AUM LifeTech's FANA ASO RNA silencing technology is key to the successful development of nucleic acid therapies. Our goal is to successfully address some of the challenges in therapeutic development using our next-generation FANA ASO RNA silencing technology. AUM’s RNA silencing and modulation technology can be used to effectively target and silence various forms of RNA, including mRNA, microRNA, and long non-coding RNA. AUM LifeTech has established several key collaborations and is currently in the discovery and preclinical stages of developing treatments for a variety of genetic diseases.
AUM LifeTech, Inc.
Philadelphia,Pennsylvania,United States of America
unclear
January 01, 2013
contact@aumlifetech.com

Enterprise Profile

Industrial Sector
New Drug Development
Technology
Targeted Technology Nucleic Acid Technology
Concept
Disease Treatment
Application Scenarios
Innovative Drugs Small Nucleic Acid Drugs